Note: Ingredients listed on restricted chemical lists
EC/CAS
202-013-9/90-72-2
Name of the chemical
2,4,6-tris(dimethylaminomethyl)phenol
Concentration
<5
General Information
Revision date
2019-11-05
Product name
Curing Solution 6009
1.2.1 Relevant identified uses
Professional application of coatings and inks
1.2.2. Uses advised against
Reason
Emergency telephone
+44 (0)191 469 6111, +44 (0)191 438 3711, +44 (0)344 892 0111, +353 (0)1 809 2566
Icons in SDS
Company Information
company name
International Paint Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
sdsfellinguk@akzonobel.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H317, H318
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
Danger
Hazard statements
Causes serious eye damage. Causes skin irritation. May cause an allergic skin reaction.
Precautionary statements
General Not applicable.
Prevention
Wear protective gloves. Wear eye or face protection. Avoid breathing vapour.
Response
IF ON SKIN: Take off contaminated clothing and wash it before reuse. IF IN EYES: Rinse cautiously with water for several minutes. Immediately call a POISON CENTER or physician.
Storage
Not applicable.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
Hazardous Ingredients
2,4,6-tris(dimethylaminomethyl)phenol
Supplemental label elements
elements
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Skin Irrit. 2, H315 Eye Dam. 1, H318 Skin Sens. 1, H317 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
